Use of 4-pyridylmethylphthalazines for cancer treatment

Details Use of 4-pyridylmethylphthalazines for cancer treatment Use of 4-pyridylmethylphthalazines for cancer treatment

A - Human Necessities

61

K

A61K 31/50 (2006.01) A61K 31/525 (2006.01) A61K 33/24 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2457848

Patients suffering from renal carcinoma are treated with a 4-pyridylmethyl- phthalazine anti-angiogenesis agents. Patients having different tumor types, e.g. renal cancer, are treated with a 4-pyridylmethyl-phthalazine anti- angiogenesis agent while undergoing chemotherapy.

Selon l'invention, des patients souffrant de cancer rénal sont traités avec un agent anti-angiogenèse à base de 4-pyridylméthylphtalazines. Des patients atteints de différents types de tumeurs, comme le cancer rénal, sont traités avec un agent anti-angiogenèse à base de 4-pyridylméthylphtalazines pendant leur traitement chimiothérapeutique.

Affiliated with

Also associated with

Rating

Use of 4-pyridylmethylphthalazines for cancer treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 4-pyridylmethylphthalazines for cancer treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 4-pyridylmethylphthalazines for cancer treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1685890